The researchers created two testing models: a “Brain-only” model using human-induced pluripotent stem cell (iPSC)-derived ...

We recently showed that NPCs derived from human induced pluripotent stem cells (iPSCs) represent an effective model system for mtDNA disease drug discovery (Lorenz et al, Cell Stem Cell 2017). Here, ...

The industry-trusted 2nd iPSC-Derived Cell Therapies Summit provides a dedicated forum to voice challenges, collaborate and spark conversations with the community committed to advancing iPSC ...

Through multiple experiments, the team demonstrated that placenta-derived IL1α significantly enhanced the proliferation of liver progenitor cells called hepatoblasts. "We achieved a prominent ...

SUZHOU, China, April 15, 2025 /PRNewswire/ --In January 2025 (U.S. time), the U.S. Food and Drug Administration (FDA) officially approved the Investigational New Drug (IND) application submitted ...

By promoting liver progenitor cell expansion through a specific ... More information: Yoshiki Kuse et al, Placenta-derived factors contribute to human iPSC-liver organoid growth, Nature ...

Two presentations will be featured: one focusing on enhancing the effectiveness of iPSC-derived allogeneic therapies in tumor elimination, and another discussing the generation of CAR T cells from ...

can greatly increase growth of human stem cell-derived liver organoids. By promoting liver progenitor cell expansion through a specific signaling pathway, this method offers a promising route to ...

The approval of XellSmart's clinical trial, along with the special exemption granted, signifies the FDA's recognition of XellSmart's well-established clinical-grade iPSC-derived cell drug ...